Maximus, Inc. MMS
The biggest changes in the 10-K filed Nov 20, 2025, in management's words
10-K, Item 7This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.
Cash from operations
Big change, FY to Sep 30, 2025 vs Sep 30, 2024
The MD&A has no sentence that names a cause for this change.
Gross margin
Change, FY to Sep 30, 2025 vs Sep 30, 2024
The MD&A has no sentence that names a cause for this change.
Operating margin
Change, FY to Sep 30, 2025 vs Sep 30, 2024
The MD&A has no sentence that names a cause for this change.
Net income
Change, FY to Sep 30, 2025 vs Sep 30, 2024
The MD&A has no sentence that names a cause for this change.
Revenue
Change, FY to Sep 30, 2025 vs Sep 30, 2024
“Our revenue growth was driven by our clinical programs, including medical assessments, as well as from support provided to the Federal Emergency Management Agency (FEMA).”
Read it in the 10-K
“Our medical assessment revenue benefitted from increased volumes, including those driven by the Honoring our Pact Act, which had necessitated a contract rebid to expand the scale of these arrangements, as well as volume increases from underlying assessment demands.”
Read it in the 10-K
What management said, year by year
The cause given in each 10-K, 2 fiscal years, newest first · MD&A (Item 7)
Each bar is how the line changed that year (from the same 10-K's XBRL). Under it, the sentence in that year's MD&A that names the line, a direction and a cause, word for word. A year with no sentence says so.
Revenue
2 of 2 years explained-
FY 2025 +2.4%
“Our revenue growth was driven by our clinical programs, including medical assessments, as well as from support provided to the Federal Emergency Management Agency (FEMA).”
Read it in the FY 2025 10-K“Our medical assessment revenue benefitted from increased volumes, including those driven by the Honoring our Pact Act, which had necessitated a contract rebid to expand the scale of these arrangements, as well as volume increases from underlying assessment demands.”
Read it in the FY 2025 10-K -
FY 2024 +8.2%
“Our revenue and margin growth has principally been driven by volume growth and strong performance on our contracts relating to clinical assessments.”
Read it in the FY 2024 10-K
Gross margin
0 of 2 years explained-
FY 2025 +1.0 pts
The FY 2025 MD&A has no sentence that names a cause for this change.
-
FY 2024 +2.6 pts
The FY 2024 MD&A has no sentence that names a cause for this change.
Operating margin
0 of 2 years explained-
FY 2025 +0.5 pts
The FY 2025 MD&A has no sentence that names a cause for this change.
-
FY 2024 +3.2 pts
The FY 2024 MD&A has no sentence that names a cause for this change.
Net income
0 of 2 years explained-
FY 2025 +3.9%
The FY 2025 MD&A has no sentence that names a cause for this change.
-
FY 2024 +89.7%
The FY 2024 MD&A has no sentence that names a cause for this change.
Cash from operations
0 of 2 years explained-
FY 2025 -16.7%
The FY 2025 MD&A has no sentence that names a cause for this change.
-
FY 2024 +63.9%
The FY 2024 MD&A has no sentence that names a cause for this change.
Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K
Sources
The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.
Also
Financials: the numbers year by year.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MMS/export.csv") into a cell.